What is the appropriate evaluation and management for a patient with a 2‑week sub‑acute cough without fever, dyspnea, chest pain, weight loss, or other systemic symptoms?

Subacute Cough Management

For a patient with a 2-week subacute cough without fever, dyspnea, chest pain, weight loss, or other systemic symptoms, you should reassure the patient that this is most likely postinfectious cough from a recent viral upper respiratory infection, avoid antibiotics, and provide symptomatic management with follow-up in 4-6 weeks if the cough persists beyond 8 weeks. 1

Classification and Timeline

This patient has subacute cough (defined as 3-8 weeks duration), though at 2 weeks they are technically still in the acute phase transitioning to subacute 1. The most common cause of subacute cough is postinfectious cough following viral upper respiratory tract infections 1, 2.

Initial Assessment: Rule Out Red Flags

First, confirm the absence of warning signs that would require immediate evaluation 1, 2:

• Hemoptysis (blood in sputum)
• Significant dyspnea at rest
• Chest pain (especially pleuritic)
• Fever ≥38°C (100.4°F)
• Unintentional weight loss
• Night sweats
• Immunocompromised state

Since your patient has none of these symptoms, urgent diagnostic workup is not indicated 3, 1.

Diagnostic Approach

What You DON'T Need:

• No chest X-ray required - Only indicated if abnormal vital signs or clinical signs suggesting pneumonia are present 3. Your patient has normal vital signs and no respiratory distress.

• No antibiotics indicated - When there is no clinical or radiographic evidence of pneumonia and vital signs/lung exam are normal, routine antibiotics are not recommended 3. Antibiotics for acute bronchitis decrease cough duration by only 0.5 days while exposing patients to adverse effects 4.

• No routine laboratory testing - CRP and procalcitonin are only useful when pneumonia is suspected 3.

What You SHOULD Do:

1. Focused history to identify:

   • Recent upper respiratory infection (most likely cause) 1, 2
   • Environmental or occupational exposures 1
   • Medication history (ACE inhibitors, sitagliptin) 1
   • Underlying conditions (asthma, COPD, GERD) that could be exacerbated 1

2. Physical examination focusing on:

   • Lung auscultation (should be clear; crackles or diminished breath sounds would suggest pneumonia) 3
   • Vital signs (tachypnea, tachycardia, fever would be concerning) 3
   • Signs of postnasal drip or rhinosinusitis 1

3. Use a validated cough severity tool to objectively assess symptoms and track response 1

Management Strategy

Symptomatic Treatment:

The evidence does not support the following for acute/subacute cough 4:

• Antitussives
• Honey
• Antihistamines
• Anticholinergics
• Oral NSAIDs
• Inhaled or oral corticosteroids

Patient Education (Critical Component):

• Set realistic expectations: Cough typically lasts 2-3 weeks after viral infections 4
• Explain this is self-limiting and will resolve without antibiotics 2, 4
• Describe it as a "chest cold" rather than "bronchitis" to reduce antibiotic expectations 4

Follow-Up Plan:

Schedule follow-up in 4-6 weeks (by phone or clinic visit) 1. If cough persists beyond 8 weeks, it becomes chronic cough requiring systematic evaluation for:

• Upper airway cough syndrome (postnasal drip)
• Asthma/cough-variant asthma
• Gastroesophageal reflux disease
• Nonasthmatic eosinophilic bronchitis 1

Common Pitfalls to Avoid

1. Over-prescribing antibiotics: The most common error is prescribing antibiotics for viral bronchitis. This provides minimal benefit (0.5 day reduction in cough) while causing adverse effects and promoting resistance 4.

2. Premature extensive workup: At 2 weeks without red flags, extensive testing is premature and not cost-effective 3, 1.

3. Missing medication-induced cough: Always ask about ACE inhibitors and sitagliptin, which can cause chronic cough 1.

4. Failing to follow up: Without scheduled follow-up, patients with evolving chronic cough may be lost to care 1.

Special Considerations

If the patient had suspected influenza within 48 hours of symptom onset, antiviral treatment could decrease antibiotic use and hospitalization 3. However, at 2 weeks post-onset, this window has passed.

If cough worsens or new symptoms develop (fever, dyspnea, chest pain), the patient should return immediately for reassessment, as this could indicate secondary bacterial pneumonia or other complications 3, 5.